Back to search results
Active, not recruiting


Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis

RHCD | {{ defaultRegistry.registryAnchorText }} NCT03073200 {{ currentLocaleObject.registryAnchorText }}

Study Purpose

The purpose of this study is to evaluate the safety and efficacy of ixekizumab in pediatric participants with moderate-to-severe plaque psoriasis. Note: the study design may differ if you reside outside of US or Canada, please consult with the appropriate investigator for more details.

Time Commitment

Your participation could last up to 132 weeks and include 34 visits to the study center.

Key Participation Requirements Tool Tip Icon

All clinical trials have rules about who can participate. This section outlines some of those rules. Please contact a study center to discuss the full set of criteria


Male Female


6 years
18 years
  • Participant (child or adolescent) must have a diagnosis of moderate-to-severe plaque-type psoriasis for at least 6 months prior to baseline as determined by the investigator
  • Male participant must agree to use a reliable method of birth control during the study
  • Female participant of childbearing potential must test negative for pregnancy and agree to use a reliable method of birth control or agree not to be sexually active during the study and for at least 12 weeks following the last dose of study medication
  • Participant and their parent or legal guardian must be able to understand and fully participate in the activities of the clinical study
  • Participant must not have any active or recent infection within 4 weeks of the first dose of study medication

Where to Participate

Where to Participate

Invalid Postal Code.
Please re-enter postal code.

{{sites.getPageStartCount()}} - {{sites.getPageEndCount()}} of {{sites.totalCount}} Results

0 of {{sites.totalCount}} Results

Distance Location Status
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
{{site.siteStatus | translate}}
Closest Location to Participate
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
{{site.siteStatus | translate}}
Other Location(s) to Participate
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
{{site.siteStatus | translate}}

To improve your experience on Lilly TrialGuide, please use the latest version of Chrome, Firefox, Safari, or Internet Explorer, with Java Script enabled.
This website is not optimized for your browser, as configured.